Hoth Therapeutic Announces That It Has Submitted its Request to Australia Ethics Board to Begin Clinical Trial of BioLexa for Atopic Dermatitis
Stock Information for Hoth Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.